Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).
about
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementPredictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study.Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis.Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsEffectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study).Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.An observational study of tocilizumab and TNF-α inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety.Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis.Interleukin 6 and rheumatoid arthritisA new alternative therapy in dermatology: tocilizumab.Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.Tocilizumab unmasks a stage-dependent interleukin-6 component in statin-induced apoptosis of metastatic melanoma cellsEvaluation of safety, efficacy and post-cessation efficacy durability of tocilizumab in patients with active rheumatoid arthritis.Safety and efficacy of tocilizumab for the treatment of rheumatoid arthritis.Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab.Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors.Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials.The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.Tocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospeEfficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia®as Biological Intensive Treatment for RA (ORBIT) study
P2860
Q27021115-3765140F-4B21-4A9E-9A1B-65AB29435EA5Q27692641-EA1501D8-5D72-4CB0-9501-35284D5B7C40Q30882161-C40A07BA-0D68-4035-9977-A43626EC10F7Q33725505-663858AA-E044-4534-8566-CDF717959390Q33809045-E262E4BA-8068-4AD2-85E3-207963CFF963Q34012929-74B993C6-4E4F-42D5-9B9F-339EB2F377F1Q34067792-3A859393-1891-46FE-9DBC-D43B3B0A6469Q34656204-ADBAABCE-0541-40DD-8775-14C840B65498Q35143956-1447BE32-91FB-4E93-B4CB-891C45135CBFQ35223223-78BF703D-B689-4559-946D-483F34F7E22FQ35415667-137AD5E0-471B-414E-A121-3FC32426CF9AQ35724900-C3566FF1-8E75-487B-9A29-7974E612DF80Q37358242-E8745E4A-53C5-4EB6-A11D-8003142B7F06Q37553940-65226637-612C-492D-BFA6-F5499961D834Q38507301-7CF2419D-1401-45F3-87F8-9B4E6EC197FFQ38827889-43AF439E-ED0D-4731-9040-DFE5B1496B29Q38870044-4F34255D-49AC-441F-8016-86E9B5685E6CQ40992087-83A2D10A-FA66-4FD4-903C-ECFF6FA43C80Q42578542-E84A9796-EFBD-49FB-B9AA-A12F72C365CFQ43752980-8FF12AA5-C34D-4DDA-9EB2-F1693A051414Q45900492-C686D7C3-9F4D-464F-B721-A80057473420Q47602038-4912059F-5D74-4A47-9A59-E080DD26B170Q50109832-F0B8607C-9A04-4481-85D1-6BDC664A2592Q50703895-59D507DE-BD4F-4505-85AC-2920BF9BF87DQ58204675-CC6E7207-AE45-4FC5-8B37-0BD3EA0F8887
P2860
Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Efficacy and tolerability of t ...... ective study (REACTION study).
@ast
Efficacy and tolerability of t ...... ective study (REACTION study).
@en
Efficacy and tolerability of t ...... lts from a retrospective study
@nl
type
label
Efficacy and tolerability of t ...... ective study (REACTION study).
@ast
Efficacy and tolerability of t ...... ective study (REACTION study).
@en
Efficacy and tolerability of t ...... lts from a retrospective study
@nl
prefLabel
Efficacy and tolerability of t ...... ective study (REACTION study).
@ast
Efficacy and tolerability of t ...... ective study (REACTION study).
@en
Efficacy and tolerability of t ...... lts from a retrospective study
@nl
P2093
P2860
P1433
P1476
Efficacy and tolerability of t ...... pective study (REACTION study)
@en
P2093
Daisuke Hoshi
Eisuke Inoue
Hideto Kameda
Hisashi Yamanaka
Kazuyoshi Saito
Kentaro Hanami
Kouichi Amano
Naoki Yunoue
Shigeki Momohara
Yoshiya Tanaka
P2860
P304
P356
10.1007/S10165-010-0366-7
10.3109/S10165-010-0366-7
P577
2010-10-16T00:00:00Z